Corps Capital Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
Corps Capital Advisors's LLY Position: Q2 2026 in Review
Corps Capital Advisors increased its Eli Lilly (LLY) stake by 25% in Q2 2026, buying an estimated $60.3K and bringing the position to 292 shares worth $350K. The position accounts for 0.28% of the portfolio, ranked #68.
Corps Capital Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Corps Capital Advisors held 292 shares of Eli Lilly worth $350K as of Q2 2026.
- Corps Capital Advisors bought 59 Eli Lilly shares in Q2 2026, an estimated $60.3K.
- Eli Lilly made up 0.28% of Corps Capital Advisors's portfolio in Q2 2026, its #68 holding.
- Corps Capital Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
- 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Corps Capital Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.